Chemed Corporation
CHE
$439.36
-$2.19-0.50%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.07% | 4.06% | 6.45% | 7.55% | 8.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.07% | 4.06% | 6.45% | 7.55% | 8.52% |
| Cost of Revenue | 5.90% | 8.23% | 11.06% | 11.44% | 9.62% |
| Gross Profit | -5.09% | -3.65% | -1.85% | 0.62% | 6.54% |
| SG&A Expenses | 2.21% | -1.08% | 0.18% | -0.17% | 2.10% |
| Depreciation & Amortization | 3.86% | 2.84% | 2.53% | 2.19% | 2.24% |
| Other Operating Expenses | -43.90% | -- | 96.45% | 96.73% | 97.51% |
| Total Operating Expenses | 5.11% | 6.17% | 8.63% | 8.80% | 7.91% |
| Operating Income | -14.30% | -7.63% | -5.30% | 0.83% | 11.99% |
| Income Before Tax | -15.03% | -10.94% | -6.20% | 0.20% | 12.91% |
| Income Tax Expenses | -12.51% | -7.11% | -1.67% | 13.15% | 26.95% |
| Earnings from Continuing Operations | -15.86% | -12.17% | -7.60% | -3.51% | 8.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.86% | -12.17% | -7.60% | -3.51% | 8.94% |
| EBIT | -14.30% | -7.63% | -5.30% | 0.83% | 11.99% |
| EBITDA | -11.88% | -6.18% | -4.17% | 1.08% | 10.68% |
| EPS Basic | -11.26% | -8.29% | -4.77% | -1.52% | 10.36% |
| Normalized Basic EPS | -9.02% | -6.81% | -5.04% | 0.43% | 12.18% |
| EPS Diluted | -10.65% | -7.77% | -4.42% | -1.34% | 10.52% |
| Normalized Diluted EPS | -8.36% | -6.25% | -4.66% | 0.61% | 12.34% |
| Average Basic Shares Outstanding | -4.94% | -4.15% | -3.12% | -2.15% | -1.25% |
| Average Diluted Shares Outstanding | -5.59% | -4.71% | -3.54% | -2.35% | -1.40% |
| Dividend Per Share | 21.05% | 22.22% | 23.53% | 25.00% | 20.25% |
| Payout Ratio | 0.36% | 0.33% | 0.30% | 0.26% | 0.09% |